Nan Shan Life Insurance’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-162,400
Closed -$2.78M 80
2017
Q1
$2.78M Sell
162,400
-87,600
-35% -$1.53M 0.07% 71
2016
Q4
$4.48M Sell
250,000
-1,063,082
-81% -$19.3M 0.17% 55
2016
Q3
$27.3M Buy
1,313,082
+1,073,082
+447% +$26.6M 0.79% 33
2016
Q2
$6.45M Sell
240,000
-80,000
-25% -$2.19M 0.25% 48
2016
Q1
$8.67M Hold
320,000
0.38% 47
2015
Q4
$9.29M Hold
320,000
0.53% 37
2015
Q3
$8.68M Buy
+320,000
New +$9.06M 0.48% 43

Other funds holding NVO

Nan Shan Life Insurance's NVO Position: Q2 2017 in Review

Nan Shan Life Insurance sold out of Novo Nordisk (NVO) in Q2 2017, closing a stake of 162,400 shares — an estimated $2.78M sold.

Nan Shan Life Insurance first reported a position in NVO in Q3 2015 and held it in 7 quarters. The position peaked at $27.3M in Q3 2016. 484 funds tracked by Wall St. Rank hold NVO as of Q2 2017.

  • Nan Shan Life Insurance reported no remaining Novo Nordisk position as of Q2 2017 after selling out during the quarter.
  • Nan Shan Life Insurance sold 162,400 Novo Nordisk shares in Q2 2017, an estimated $2.78M.
  • Nan Shan Life Insurance first reported a position in Novo Nordisk in Q3 2015 and held it in 7 quarters.
  • Nan Shan Life Insurance's Novo Nordisk position peaked at $27.3M in Q3 2016.
  • 484 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2017.

Based on Nan Shan Life Insurance's 13F filing for Q2 2017, filed 20 Jun 2018.